We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.88B
AUM Growth
-$312M
Cap. Flow
-$314M
Cap. Flow %
-16.69%
Top 10 Hldgs %
23.69%
Holding
207
New
35
Increased
64
Reduced
46
Closed
62

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$37.1M
2
CMCSA icon
Comcast
CMCSA
+$36.9M
3
ILMN icon
Illumina
ILMN
+$32.3M
4
C icon
Citigroup
C
+$29.7M
5
VTRS icon
Viatris
VTRS
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 20.32%
2 Consumer Discretionary 17.17%
3 Energy 12.32%
4 Healthcare 9.35%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVA icon
76
Avista
AVA
$3.2B
$8.07M 0.43%
230,457
+91,668
+66% +$3.12M
BABA icon
77
Alibaba
BABA
$317B
$7.96M 0.42%
110,001
+9,761
+10% +$715K
SON icon
78
Sonoco
SON
$5.72B
$7.86M 0.42%
135,903
+38,090
+39% +$2.17M
KHC icon
79
Kraft Heinz
KHC
$29.6B
$7.74M 0.41%
+209,817
New +$7.62M
CMP icon
80
Compass Minerals
CMP
$1.13B
$7.49M 0.4%
+475,604
New +$9.98M
MG icon
81
Mistras Group
MG
$502M
$7.48M 0.4%
782,657
-36,834
-4% -$307K
GEO icon
82
The GEO Group
GEO
$4.04B
$7.34M 0.39%
519,812
-25,382
-5% -$302K
FARO
83
DELISTED
Faro Technologies
FARO
$7.3M 0.39%
339,411
-831
-0.2% -$18K
EGHT icon
84
8x8 Inc
EGHT
$324M
$7.15M 0.38%
2,649,022
+571,245
+27% +$1.73M
BLCO icon
85
Bausch + Lomb
BLCO
$6.01B
$6.82M 0.36%
+394,067
New +$6.12M
M icon
86
Macy's
M
$6.55B
$6.67M 0.35%
333,519
-629,291
-65% -$12.2M
ZD icon
87
Ziff Davis
ZD
$2B
$6.12M 0.33%
97,138
+10,287
+12% +$683K
HCSG icon
88
Healthcare Services Group
HCSG
$1.5B
$6.04M 0.32%
484,237
+77,649
+19% +$861K
WRBY icon
89
Warby Parker
WRBY
$3.26B
$5.68M 0.3%
417,256
+173,861
+71% +$2.31M
SHLS icon
90
Shoals Technologies Group
SHLS
$1.44B
$5.52M 0.29%
+493,779
New +$6.79M
OMCL icon
91
Omnicell
OMCL
$1.7B
$5.35M 0.28%
183,115
+78,512
+75% +$2.38M
LOCO icon
92
El Pollo Loco
LOCO
$463M
$4.78M 0.25%
491,244
+325,963
+197% +$2.93M
ROG icon
93
Rogers Corp
ROG
$2.29B
$4.78M 0.25%
+40,275
New +$4.71M
AVB icon
94
AvalonBay Communities
AVB
$26.3B
$4.75M 0.25%
+25,603
New +$4.6M
EXE
95
Expand Energy Corp
EXE
$22.6B
$4.69M 0.25%
+52,809
New +$4.24M
KSS icon
96
Kohl's
KSS
$2.16B
$4.54M 0.24%
155,705
-261,044
-63% -$7M
SANM icon
97
Sanmina
SANM
$10.7B
$4.49M 0.24%
72,178
-164,806
-70% -$9.58M
CART icon
98
Maplebear
CART
$11.7B
$4.48M 0.24%
+120,243
New +$3.52M
FIS icon
99
Fidelity National Information Services
FIS
$21.9B
$4.41M 0.23%
59,446
-86,068
-59% -$5.6M
MNRO icon
100
Monro
MNRO
$368M
$4.35M 0.23%
+137,868
New +$4.26M

Similar funds

Invenomic Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Invenomic Capital Management held 207 positions worth $1.88B, down 14% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $314M in Q1 2024, closing 62 positions and reducing 46 holdings. Its most notable exit was QuidelOrtho, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Invenomic Capital Management opened a new position in Archer Daniels Midland worth $37.9M.

  • Invenomic Capital Management's largest Q1 2024 buy was Archer Daniels Midland: 603,681 shares worth $37.9M.
  • Invenomic Capital Management added most to 3M in Q1 2024, an estimated $23.6M increase.
  • Invenomic Capital Management's biggest Q1 2024 reduction was Illumina, cutting an estimated $32.3M.
  • Invenomic Capital Management fully exited QuidelOrtho in Q1 2024, selling an estimated $37.1M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.88B portfolio in Q1 2024.
  • Invenomic Capital Management opened 35 new positions and closed 62 in Q1 2024.
  • Invenomic Capital Management's portfolio value fell 14% quarter-over-quarter to $1.88B.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.